• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Thia fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Thia fatty acids

Recent Advances in the Study of Sulfonium, (3-carboxy-3-hydroxypropyl)dimethyl-, inner salt (CAS: 194034-30-5)

The compound Sulfonium, (3-carboxy-3-hydroxypropyl)dimethyl-, inner salt (CAS: 194034-30-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This sulfonium-based molecule, characterized by its unique zwitterionic structure, has shown promising potential in various applications, including drug delivery, enzyme inhibition, and metabolic pathway modulation. Recent studies have focused on elucidating its physicochemical properties, biological activities, and potential therapeutic applications.

A study published in the Journal of Medicinal Chemistry (2023) explored the role of this sulfonium compound as a potent inhibitor of key enzymes involved in oxidative stress pathways. The researchers demonstrated that the compound's ability to act as a methyl donor and its zwitterionic nature contribute to its high affinity for enzyme active sites, making it a promising candidate for the development of novel therapeutics targeting oxidative stress-related diseases such as neurodegenerative disorders and cancer.

In another groundbreaking study (Nature Chemical Biology, 2024), the compound was investigated for its potential in targeted drug delivery systems. The researchers utilized its unique chemical structure to develop pH-responsive nanocarriers capable of selectively releasing therapeutic agents in tumor microenvironments. The results showed enhanced drug accumulation in tumor tissues and reduced off-target effects, highlighting the compound's utility in improving the efficacy and safety of cancer treatments.

Further research has also explored the metabolic fate of Sulfonium, (3-carboxy-3-hydroxypropyl)dimethyl-, inner salt in biological systems. A recent pharmacokinetic study (Drug Metabolism and Disposition, 2023) revealed that the compound undergoes rapid absorption and distribution, with a favorable safety profile in preclinical models. These findings support its potential for further development as a therapeutic agent or as a component in drug formulations.

Looking ahead, ongoing research is focusing on optimizing the synthesis of this sulfonium compound to improve yield and purity, as well as exploring its interactions with other biomolecules. The compound's versatility and unique properties position it as a valuable tool in chemical biology and a promising candidate for future pharmaceutical applications. Continued investigation into its mechanisms of action and therapeutic potential is expected to yield further insights and opportunities for innovation in the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)